Publicaciones en colaboración con investigadores/as de Hospital Ramón y Cajal (10)

2023

  1. Prevalence Rates of Arterial Hypertension According to the Threshold Criteria of 140/90 or 130/80 mmHg and Associated Cardiometabolic and Renal Factors: SIMETAP-HTN Study

    Medicina (Lithuania), Vol. 59, Núm. 10

2022

  1. Evaluation of prophylaxis in primary prevention with acetylsalicylic acid in people with diabetes: A scoping review

    Semergen, Vol. 48, Núm. 4, pp. 275-292

  2. SEMERGEN positioning on approaching chronic heart failure in primary care

    Semergen, Vol. 48, Núm. 2, pp. 106-123

  3. The natriuretic peptides in the diagnosis of heart failure in primary care setting

    Semergen, Vol. 48, Núm. 7

2021

  1. COVID-19 vaccine and anticoagulation patients at high cardiovascular risk. SEMERGEN recommendations

    Semergen

2017

  1. Consensus on the Statin of Choice in Patients with Impaired Glucose Metabolism: Results of the DIANA Study

    American Journal of Cardiovascular Drugs, Vol. 17, Núm. 2, pp. 135-142

  2. Enfermedad renal crónica y dislipidemia

    Clinica e Investigacion en Arteriosclerosis

2016

  1. Consenso Delphi sobre el manejo de la dislipidemia en pacientes con alteración del metabolismo de la glucosa: Estudio Diana

    Clinica e Investigacion en Arteriosclerosis, Vol. 28, Núm. 3, pp. 132-140

  2. Delphi consensus on the diagnosis and management of dyslipidaemia in chronic kidney disease patients: A post hoc analysis of the DIANA study

    Nefrologia, Vol. 36, Núm. 6, pp. 679-686

2012

  1. Cost-effectiveness analysis of rosuvastatin vs generic atorvastatin in Spain

    Journal of Medical Economics, Vol. 15, Núm. SUPPL. 1, pp. 45-54